Faculty, Staff and Student Publications

Language

English

Publication Date

4-3-2026

Journal

Communications Engineering

DOI

10.1038/s44172-026-00660-1

PMID

41933037

PMCID

PMC13049096

PubMedCentral® Posted Date

4-3-2026

PubMedCentral® Full Text Version

Post-print

Abstract

The development of safe and effective maternal-fetal therapeutics is significantly hindered by chronic underfunding, inequitable access to specialized care, and persistent sociopolitical stigmas surrounding women’s health. Addressing these challenges will require interdisciplinary collaboration between clinicians, scientists, and engineers to design accessible therapeutics for maternal-fetal healthcare.

Keywords

Drug delivery, Nanoparticles

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.